the republic logo

Stryker says it will buy Small Bone Innovations for up to $375M in cash

Share/Save/Bookmark

NEW YORK — Medical device maker Stryker said Monday it will buy bone and joint replacement maker Small Bone Innovations for up to $375 million in cash.

Stryker said the deal will cost it as much as $285 million after tax benefits. Small Bone Innovations makes products that are used to treat conditions that affect the ankle, fingers, wrist, and elbow. Its main product is the STAR Ankle system, a total ankle replacement device with three pieces =that does not need cement. Stryker said Small Bone Innovations had $48 million in product sales in 2014.

Small Bone Innovations is based in Morrisville, Pennsylvania, with facilities in France and Germany. Stryker, of Kalamazoo, Michigan, said it expects to complete the acquisition during the third quarter. The company said the purchase will reduce its 2014 net income by 2 cents per share excluding one-time charges.

Needham & Co. analyst Michael Matson said the purchase makes Stryker more competitive in the foot and ankle device market, and STAR Ankle "fills a noticeable hole in Stryker's foot and ankle portfolio."

Shares of Stryker Corp. rose 28 cents to $84.25 in afternoon trading.

Think your friends should see this? Share it with them!

All comments are moderated before posting. Your email address must be verified with Disqus in order for your comment to appear.
View our commenting guidelines and FAQ's here.

Story copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Feedback, Corrections and Other Requests: AP welcomes feedback and comments from readers. Send an email to info@ap.org and it will be forwarded to the appropriate editor or reporter.


We also have more stories about:
(click the phrases to see a list)

Category:

Follow The Republic:

All content copyright ©2014 The Republic, a division of Home News Enterprises unless otherwise noted.
All rights reserved. Privacy policy.